Point prevalence survey on antibiotic use in a croatian infectious disease hospital

Journal of Chemotherapy

Volumn 25, Issue 4, 2013, Pages 222-228

  Pristaš, Irina ^a   Baršić, Bruno ^a   Butić, Iva ^a   Zarb, Peter ^b   Goossens, Herman ^c   Tambić Andrašević, Arjana ^a  

^a Croatia   (Croatia)

^b Mater Dei Hospital   (Croatia)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Antimicrobial consumption; Croatia; Point prevalence surveys

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZITHROMYCIN; BENZATHINE; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLOXACILLIN; DORIPENEM; DOXYCYCLINE; ERTAPENEM; ETHAMBUTOL; FLUCLOXACILLIN; FLUCONAZOLE; MOXIFLOXACIN; NETILMICIN; NITROFURANTOIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PROCAINE PENICILLIN; RIFAMPICIN; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; BONE AND JOINT INFECTIONS; CARDIOVASCULAR INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CROATIA; DRUG USE; EAR INFECTION; FEMALE; HEALTH SURVEY; HUMAN; INFECTION; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NOSE INFECTION; PHARYNGITIS; PRESCRIPTION; PREVALENCE; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

EID: 84880925521     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947812Y.0000000065     Document Type: Article

References (39)

1. Loeffler JM, Garbino J, Lew D, Harbarth S, Rohner P. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis. 2003;35:843-50.
2. Cooke FJ, Bryony DF, Lawson W, Jacklin A, Holmes A. Multidisciplinary hospital antibiotic stewardship: a West London model. Clin Govern Int J. 2004;9:237-43.
3. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-587.
4. Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8:278-82.
5. Usluer G, Ozgunes I, Leblebicioglu H, Turkish Antibiotic Utilization Study Group. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4:16.
6. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients. Arch Intern Med. 2003;163:972-8.
7. Jarvis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect Control Hosp Epidemiol. 1996;17:490-5.
8. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis. 1988; 157:869-76.
9. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H, European Survaillance of Antibiotic Comsuption (ESAC) Project Group. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother. 2006;58:159-167.
10. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H, ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol. 2004;58:419-428.
11. de With K, Bergner J, Bühner R, Dörje F, Gonnermann C, Haber M, et al. Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II). Int J Antimicrob Agents. 2004;24:15-20.
12. Müller-Pebody B, Muscat M, Pelle B, Klein BM, Brandt CT, Monnet DL. Increase and change in pattern of hospital antimicrobial usex, Denmark, 1997-2001. J Antimicrob Chemother. 2004;54:1122-1126.
13. Kritsotakis EI, Gikas A. Surveillance of antibiotic use in hospitals: methods, trends and targets. Clin Microbiol Infect. 2006;12:701-4.
14. Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) pointprevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49:1496-504.
15. Dimiņa E, Kula M, Caune U, Vigante D, Liepiņs M, Zeidaka L, et al. Repeated prevalence studies on antibiotic use in Latvia, 2003-2007. Euro Surveill. 2009;14:19307.
16. Vlahovic-Palcevski V, Dumpis U, Mitt P, Gulbinovic J, Struwe J, Palcevski G, et al. Benchmarking antimicrobial drug use at university hospitals in five European countries. Clin Microbiol Infect. 2007;13:277-83.
17. Yilmaz GR, Bulut C, Yildiz, Arslan S, Yetkin MA, Demiröz AP. Examining antibiotic use at an education and research hospital in Turkey: point prevalence results. Turk J Med Sci. 2009;39:125-31.
18. Seaton RA, Nathwani D, Burton P, McLaughlin C, MacKenzie AR, Dundas S, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT). Int J Antimicrob Agents. 2007;29:693-9.
19. Ciofi Degli Atti ML, Raponi M, Tozzi AE, Ciliento G, Ceradini J, Langiano T. Point prevalence study of antibiotic use in a paediatric hospital in Italy. Euro Surveill. 2008;13:19003.
20. ESAC3 Hospital Care Subproject-Protocol Pan European Point Prevalence Survey 2009. 2010. http://app.esac.ua.ac.be/public/ (accessed September 2012).
21. WHO Collaborating Centre for Drug Statistics Methodology. 2011. http://www.whocc.no/ (accessed September 2012).
22. Schönwald S, Barsic B, Beus A, et al. Priručnik za liječenje i sprečavanje infektivnih bolesti: džepni vodić. Zagreb: Tisak; 2001.
23. Fonseca LG, Conterno LO. Audit of antibiotic use in a Brazilian University Hospital. Brazil J Infect Dis. 2004;8:272-80.
24. Lee MK, Chiu CS, Chow VC, Lam RK, Lai RW. Prevalence of hospital infection and antibiotic use at a University Medical Center in Hong Kong. J Hosp Infect. 2007;65:341-7.
25. Gikas A, Pediaditisy J, Papadakis JA, Starakis J, Levidiotou S, Nikolaides P, et al. Prevalence study of hospital-acquired infections in 14 Greek hospitals: planning from the local to the national surveillance level. J Hosp Infect. 2002;50:269-75.
26. Berild D, Ringertz SH, Lelek M. Appropriate antibiotic use according to diagnoses and bacteriological findings: report of 12 point-prevalence studies on antibiotic use in a University Hospital. Scand J Infect Dis. 2002;34:56-60.
27. The ESAC PPS of patterns of antibiotic use in 50 European hospitals in 2008. 2010. http://www.blackwellpublishing.com/eccmid19/abstract.asp?id=73988 (accessed September 2012).
28. Erntell M, Ansari F, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) pointprevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49:1496-504.
29. Kanerva M, Ollgren J, Lyytikainen O. Antimicrobial use in Finnish acute care hospitals: data from national prevalence survey, 2005. J Antimicrob Ther. 2007;60:440-4.
30. Raveh D, Levy Y, Schlesinger Y, Greenberg A, Rudensky B, Yinnon AM. Longitudinal surveillance of antimicrobial use in the hospital. QJM. 2001;94:141-52.
31. Di Giammarino L, Bihl F, Bissig M, Bernasconi B, Cerny A, Bernasconi E. Evaluation of prescription practices of antibiotics in medium-sized Swiss hospital. Swiss Med Wkly. 2005;135:710-4.
32. Tambic Andrasevic A, Baudoin T, Vukelic D, Matanović SM, Bejuk D, Puzevski D, et al. ISKRA guidelines on sore throat: diagnostic and therapeutic approach - Croatian National Guidelines. Lijec Vjesn. 2009;131:181-91.
33. Skerk V, Tambic Andrasevic A, Andrasevic S, Susić E, Dzepina AM, Madarić V, et al. ISKRA guidelines on antimicrobial treatment and prophylaxis of urinary tract infections - Croatian national guidelines. Lijec Vjesn. 2009;131:105-18.
34. Kalenic S, Pal MP, Palcevski V, Horvatić J, Mestrović T, Barsić B, et al. Guidelines for prevention, control and treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Lijec Vjesn. 2008;130 (Suppl 1):7-32.
35. Francetic I, Sardelic S, Bukovski S, Santini M, Betica-Radić L, Belina D, et al. ISKRA guidelines for antimicrobial prophylaxis in surgery - Croatian National Guidelines. Lijec Vjesn. 2010;132:203-17.
36. Dean B, Lawson W, Jacklin A, Rogers T, Azadian B, Holmes A, et al. The use of serial point-prevalence studies to investigate hospital anti-infective prescribing. Int J Pharm Pract. 2002: 10:121-5.
37. Cizman M, Beovic B, Krcmery V, Barsic B, Tamm E, Ludwig E, et al. Antibiotic policies in Central Eastern Europe. Int J Antimicrob Agents. 2004;24:199-204
38. Bruce J, MacKenzie FM, Cookson B, Mollison J, van der Meer JW, Krcmery V, et al. Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother. 2009;64:853-60.
39. Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, et al. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother. 2011; 66:443-9.